YY1 expression predicts favourable outcome in follicular lymphoma

Journal of Clinical Pathology

Volumn 64, Issue 2, 2011, Pages 125-129

  Naidoo, Khimara ^a   Clay, Vanessa ^b   Hoyland, Judith A ^a   Swindell, Ric ^c   Linton, Kim ^a,c   Illidge, Timothy ^a,c   Radford, John A ^a,c   Byers, Richard J ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; KI 67 ANTIGEN; PROTEIN; QUANTUM DOT; TRANSCRIPTION FACTOR YY1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MACROPHAGE; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL; T LYMPHOCYTE; VALIDATION STUDY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YY1 TRANSCRIPTION FACTOR;

EID: 79151475686     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.078188     Document Type: Article

References (12)

1. Johnson NA, Gascoyne RD. Gene expression signatures in follicular lymphoma: are they ready for the clinic? Haematologica 2008;93:982-7.
2. Wang CC, Chen JJ, Yang PC. Multifunctional transcription factor YY1: a therapeutic target in human cancer? Expert Opin Ther Targets 2006;10:253-66.
3. Seligson D, Horvath S, Huerta-Yepez S, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 2005;27:131-41.
4. de Nigris F, Botti C, de Chiara A, et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer 2006;42:2420-4.
5. Chinnappan D, Xiao D, Ratnasari A, et al. Transcription factor YY1 expression in human gastrointestinal cancer cells. Int J Oncol 2009;34:1417-23.
6. Sakhinia E, Glennie C, Hoyland JA, et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood 2007;109:3922-8.
7. Byers RJ, Sakhinia E, Joseph P, et al. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 2008;111:4764-70.
8. Brankin B, Skaar TC, Brotzman M, et al. Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:1109-15.
9. Berchuck A, Iversen ES, Lancaster JM, et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Research 2005;11:3686-96.
10. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-7.
11. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-13.
12. Greenbaum D, Colangelo C, Williams K, et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003;4:117.